China Pharma Holdings (CPHI) EBIT Growth (3y) (2013 - 2026)
China Pharma Holdings (CPHI) EBIT Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.98 Bn | 43.02 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.07 Bn | 39.42 Bn | 2.15 Bn | 29.31% |
| 3 | Zoetis | 31.53 Bn | 29.85 Bn | 1.05 Bn | 4.24% |
| 4 | Takeda Pharmaceutical | 28.60 Bn | 22.80 Bn | 5.10 Bn | 0.90% |
| 5 | United Therapeutics | 22.13 Bn | 19.47 Bn | 683.80 Mn | 1.82% |
| 6 | Viatris | 18.75 Bn | 17.86 Bn | 1.46 Bn | -74.25% |
| 7 | Neurocrine Biosciences | 15.53 Bn | 15.14 Bn | 935.80 Mn | 27.21% |
| 8 | Elanco Animal Health | 11.69 Bn | 11.16 Bn | 798.00 Mn | 35.42% |
| 9 | Dr Reddys Laboratories | 10.13 Bn | 9.97 Bn | - | - |
| 10 | China Pharma Holdings | 41.74 Mn | 41.43 Mn | 83,566.00 | -46.40% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -41.13% |
| Dec 31, 2025 | -0.88% |
| Sep 30, 2025 | 3.02% |
| Jun 30, 2025 | 5.78% |
| Mar 31, 2025 | 5.94% |
| Dec 31, 2024 | -22.62% |
| Sep 30, 2024 | -12.49% |
| Jun 30, 2024 | -22.72% |
| Mar 31, 2024 | -9.57% |
| Dec 31, 2023 | -2.45% |
| Sep 30, 2023 | 9.18% |
| Jun 30, 2023 | -100.71% |
| Mar 31, 2023 | 12.79% |
| Dec 31, 2022 | 60.29% |
| Sep 30, 2022 | -2.20% |
| Jun 30, 2022 | -1.17% |
| Mar 31, 2022 | -39.73% |
| Dec 31, 2021 | 55.80% |
| Sep 30, 2021 | 26.64% |
| Jun 30, 2021 | 4.50% |